Publications

BioCentury Publications

REALIZE SIGNIFICANT DISCOUNTS ON BIOCENTURY'S PUBLICATIONS AND DATA SOLUTIONS

BioCentury is recognized as the ESSENTIAL provider of independent, informed business intelligence. Its information platform combines analysis and data to regularly affect decisions made by bio-industry leaders and investors throughout the world.

Your benefits:

New subscribers

  • Access to BioCentury's global industry analysis and data at a reduced rate for new subscribers
  • Significant discounts on a one-year, single-user subscription to two weekly publications: the flagship BioCentury, the Bernstein Report on BioBusiness and the BioCentury Part II compendium of corporate, clinical and financial transactions, as well as the daily BioCentury Extra newspaper. New subscribers that are BIOTECanada Corporate A members in good standing with less than 50 employees engaged in drug/diagnostic development are eligible.
  • 33% discount when you increase your BioCentury publications subscription to a 10-user group account
  • 33% discount to the Data Solutions -- BioCentury Online Intelligence (BCIQ) and BioCentury Archives -- for new subscribers for one year.
  • One month free trial for all publications

Current subscribers

  • 33% discount when you increase your BioCentury publications subscription to a 10-user group account
  • 33% discount when you upgrade your subscription to include the Data Solutions: BioCentury Online Intelligence (BCIQ) and BioCentury Archives

How it works:

Contact Subscriber Service Manager Andy Heller at BioCentury Publications, Inc.
Office: (781) 378-2011, Mobile: (617) 922-2257, Email: aheller@biocentury.com
Find out more: www.biocentury.com

BioCentury's mission is to provide value-added information and analysis for biotech and pharma companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of biopharmaceutical ventures. Our breadth of coverage includes corporate strategy, partnering, translational science, clinical data, public policy and the financing markets. All of this is supported by an in-house data warehouse that is now available to subscribers through BioCentury Online Intelligence (BCIQ).


BioWorld Publications

WORLDWIDE BIOTECHNOLOGY NEWS AND INFORMATION

85% off cover price for BioWorld Today and BioWorld Financial Watch for BIOTECanada Corporate A members

SAVE $3000 US if you subscribe to both publications

Enhance your success in the business of biotech with the newspaper of record for the industry. Delivering insider intelligence every business morning, you have access to a wide range of issues dramatically affecting the industry, including: Scientific milestones, capital sources and venture capital financing, corporate financial and stock performance, strategic alliances, agreements, sales and mergers, FDA and congressional actions.

Your benefits:

  • Exceptional savings on annual subscription fees
    - BioWorld Today for only US$420
    - BioWorld Insight for only US$225
  • E-mail delivery directly to you every business morning in an easy-to-read, pdf format
  • Weekly reports from BioWorld Financial Watch give you a complete view of the business side of biotechnology
  • Ability to monitor collaborations, public and private financings, clinical trials and FDA submissions, stock market activity, and underwriter and venture capital portfolio performances through one source

How it works:
Sign up directly with BIOTECanada.

Contact:
BIOTECanada
Janice Burke
Tel: 613-230-5585 ext 223
Email: janice.burke@biotech.ca

Skills at Biotech’s C-suite level have evolved: has compensation?

BIOTECanada is pleased to offer our members the 2013 BioWorld® Executive Compensation Report at 75% off the regular price of $399 US.

Why do you need this report?

The new 2013 Executive Compensation Report delivers systematic compensation data on 798 C-Level executives representing 258 companies.  This year, the scope has gone international for the first time!  The 2013 Executive Compensation Report includes 25% more companies including the addition of 87 executives representing 55 non-U.S. companies.

The 2013 Executive Compensation Report monitors, evaluates and formulates trends in the executive compensation paradigms and activities in the biotech market. The new Executive Compensation Report enables you to negotiate from a position of strength and knowledge.  It allows you to determine your rank among peers, make competent hiring offers, facilitate the annual executive review process or keep abreast of the market salary dynamics and more!

The BioWorld Executive Compensation Report 2013 provides you with complete salary, bonus and market capitalization data and rankings of six top-level job titles:
  • Chief Executive Officers
  • Chief Financial Officers
  • Chief Operating Officers
  • VPs of Research and Development
  • Chief Legal Officers
  • Heads of Business/Corporate Development
Order your electronic PDF* copy of the BioWorld Executive Compensation Report 2013 for $99.00 plus HST by contacting BIOTECanada at 613-230-5585 ext. 226 or info@biotech.ca. Please note that only credit card orders will be accepted.

* You will receive an electronic PDF version of the publication BioWorld Executive Compensation Report 2013.  This offer does not apply to the print version.


Burrill & Company

YOUR GATEWAY TO THE GLOBAL LIFE SCIENCES INDUSTRY

Burrill & Company provides a gateway into the biotechnology and life sciences global world through its publications and events. The Media Group's goal is to provide the latest insight, intelligence and information tailored for the senior executive. Stay current and interact with the leading experts and thought leaders in your field of interest. Subscribe to the publications listed below. Access market intelligence in hard copy publications, or online.

Your benefits:

Receive 30% off the list price of Burrill & Company publications, including:

  • The Burrill Stem Cell Report (4/yr), $495
  • The Burrill Stem Cell Webcast/CD-Rom, $495
  • The Burrill Personalized Medicine Report (4/yr), $495
  • Biotech 2007, $395 +shipping
  • Biotech 2008, $395 + shipping
  • The Burrill Canadian Biotech News (48/yr) $475
  • The Journal of Life Sciences (6/yr), $85
  • The Burrill Biotechnology Intelligence Report (4/yr), $999
  • Biotech 20 Year CD (1986-2006), $699

All prices in US dollars. Discounts available to BIOTECanada members only.

How it works:

Contact BIOTECanada for your membership discount code. Visit http://www.burrillandco.com/burrill/publications for a complete list of eligible publications.

Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions. Burrill publishes a wide range of bio-intelligence reports including its flagship publication, the annual "State of the Industry" report. These publications provide the latest insight, intelligence and information on the life sciences industry.



Journal of Commercial Biotechnology


The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.

Your benefits:

  • A free one year digital institutional subscription for new BIOTECanada members (must be requested within first year of membership)
  • A free one year digital institutional subscription for existing members, until June 1, 2014 
  • A 20% discount for existing members

Contact BIOTECanada for your membership discount code. 

Visit commercialbiotechnology.com for more information. 

Members should contact editor@CommercialBiotechnology.com to activate their free subscription or to purchase a discounted subscription.



Informa Business Intelligence Publications

Essential Insight for the Healthcare Industry

Informa Business Intelligence is a global leader in the field of healthcare industry information, providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry.  Informa Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis.

NEW SUBSCRIBERS

Receive special pricing on individual, online only subscriptions to the publications listed below (currently in negotiations):
 
IN VIVO - The premier strategic business resource for the biopharma, medtech, and diagnostics industries. $1,499 (Over $400 Savings)
Pharmaceutical Approvals Monthly - In-depth coverage of U.S. drug approvals, including FDA approval actions by classification. $799 (Over $250 Savings)
PharmAsia News - Highly specialized industry insight on the Asian marketplace, plus editor’s picks from the world press and English summaries of Chinese and Japanese news. $1,199 (Over $400 Savings)
Start-Up - In-depth profiles of leading-edge companies and technologies, including the most important new trends in the biopharma, medtech and diagnostics industries. $1,299 (Over $350 Savings)
“The Gold Sheet” - Insightful analysis to help you comply with U.S. and international pharmaceutical manufacturing QA/QC requirements. $799 (Over $300 Savings)
“The Pink Sheet” - Expert, in-depth analysis of biopharma regulatory, legislative, legal and business developments. $1,999 (Over $600 Savings)
“The Pink Sheet” DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. $1,899 (Over $600 Savings)
“The Rose Sheet” - Specialized coverage of regulatory, legislative, scientific, retailer, financial, marketing and legal news across the cosmetics, skin-care and fragrance industries. $1,299 (Over $450 Savings)
The RPM Report - Actionable insight on regulation, policy, FDA and CMS to apply directly to your decision-making. $1,399 (Over $500 Savings)
“The Tan Sheet” - In-depth news and analysis of the nonprescription pharmaceutical and dietary supplement industries. $1,599 (Over $450 Savings)
 

BENEFITS

Unparalleled,  24/7 access to actionable insight and critical analysis 
Email updates with the most recently published stories delivered straight to your inbox

Searchable access to a rolling 90 days of archive content
Topical RSS Feeds

HOW IT WORKS  

Please contact Julie Mair for more information on these publications and to learn about available multi-user subscription options.


You can also visit www.pharmamedtechbi.com for a complete listing of all Informa Business Intelligence publications.

Partnership Program

Platinum

AbbVie

Biogen Idec

Genzyme

vwr

Gold

Alexion